CARTESIAN THERAPEUTICS

cartesian-therapeutics-logo

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
#SimilarOrganizations #People #Financial #Website #More

CARTESIAN THERAPEUTICS

Social Links:

linkedin

Linkedin

x

X

Industry:
Biotechnology

Founded:
2016-01-01

Address:
Gaithersburg, Maryland, United States

Country:
United States

Website Url:
http://www.cartesiantherapeutics.com

Total Employee:
11+

Status:
Active

Total Funding:
2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Nginx Sitelinks Search Box


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

immpact-bio-logo

ImmPACT Bio

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

nextvivo-logo

NextVivo

NextVivo is a biotech company developing an immune organoid technology platform.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

Current Employees Featured

michael-s-singer_image

Michael S. Singer
Michael S. Singer Chief Scientific Officer, Director, Co-Founder @ Cartesian Therapeutics
Chief Scientific Officer, Director, Co-Founder
2016-01-01

not_available_image

Metin Kurtoglu
Metin Kurtoglu Chief Medical Officer @ Cartesian Therapeutics
Chief Medical Officer

murat-v-kalayoglu_image

Murat V. Kalayoglu
Murat V. Kalayoglu Co-Founder, President & Chief Executive Officer @ Cartesian Therapeutics
Co-Founder, President & Chief Executive Officer
2016-01-01

Founder


michael-s-singer_image

Michael S. Singer

murat-v-kalayoglu_image

Murat V. Kalayoglu

Investors List

national-heart-lung-and-blood-institute_image

National Heart, Lung and Blood Institute

National Heart, Lung and Blood Institute investment in Grant - Cartesian Therapeutics

schooner-capital_image

Schooner Capital

Schooner Capital investment in Venture Round - Cartesian Therapeutics

Official Site Inspections

http://www.cartesiantherapeutics.com Semrush global rank: 3.86 M Semrush visits lastest month: 3.36 K

  • Host name: 61.171.211.130.bc.googleusercontent.com
  • IP address: 130.211.171.61
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Cartesian Therapeutics"

People - Cartesian

Our leadership brings decades of clinical, R&D and management experience. Our founders previously started and sold two life science companies to Abbvie (2016) and Healthways/Tivity …See details»

Cartesian Therapeutics Establishes New Corporate Headquarters …

GAITHERSBURG, MD, March 5, 2024 – Cartesian Therapeutics, Inc. (NASDAQ: RNAC), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune …See details»

Leadership Team - Cartesian Therapeutics, Inc

Prior to joining Solvay, he was employed by Sanofi, Sterling‑Winthrop from 1979 to 1994, and Nycomed‑Amersham from 1994 to 1998 in a variety of R&D management positions in Europe …See details»

Cartesian Therapeutics - Crunchbase Company Profile …

Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. Where is Cartesian Therapeutics's headquarters? …See details»

Investor Overview - Cartesian Therapeutics, Inc

Nov 7, 2024 Cartesian Therapeutics is a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment of autoimmune diseases.See details»

Cartesian Therapeutics - LinkedIn

Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases.See details»

Cartesian Therapeutics - Overview, News & Similar companies

Jul 7, 2024 Cartesian Therapeutics contact info: Phone number: (617) 923-1400 Website: www.cartesiantherapeutics.com What does Cartesian Therapeutics do? Cartesian …See details»

Cartesian Therapeutics Strengthens Board of Directors with …

Jul 2, 2024 Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases.See details»

Cartesian Therapeutics Announces Landmark Study in The Lancet …

Jun 21, 2023 Modifying patients’ T-cells with mRNA to express a chimeric antigen receptor (rCAR-T therapy), a novel approach to treat myasthenia gravis and other autoimmune …See details»

Cartesian Therapeutics, Inc. (RNAC) - Yahoo Finance

Find the latest Cartesian Therapeutics, Inc. (RNAC) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»

Cartesian Therapeutics Initiates Clinical Trial of First RNA …

GAITHERSBURG, Md., Sept. 1, 2020 /PRNewswire/ -- Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, …See details»

Cartesian Therapeutics Announces Landmark Study in

Jun 22, 2023 The Myasthenia Gravis Foundation of America (MGFA) is the largest, leading patient advocacy organization solely dedicated to finding a cure and improved treatments for …See details»

Cartesian Therapeutics Doses Patient with First Allogeneic RNA …

Jan 25, 2022 For more information visit www.cartesiantherapeutics.com. Media Contacts: Maggie Beller for Cartesian Therapeutics Russo Partners, LLC [email protected] 646-942 …See details»

Cartesian Therapeutics Initiates Phase 2 Clinical Trial of First RNA ...

Feb 22, 2021 All investigational therapies are manufactured at Cartesian’s wholly owned, state-of-the-art cGMP manufacturing facility in Gaithersburg, MD. For more information visit …See details»

Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd …

GAITHERSBURG, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the “Company), a clinical-stage biotechnology company pioneering mRNA …See details»

Cartesian Therapeutics Highlights Progress and 2024 Strategic ...

Jan 8, 2024 Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a …See details»

Cartesian Therapeutics Highlights Progress and 2024 Strategic ...

Jan 8, 2024 Topline data from Phase 2b study of Descartes-08, the Company’s potential first-in-class mRNA CAR-T cell therapy in myasthenia gravis (MG) remains on track for mid-2024 …See details»

Science - Cartesian

Cartesian’s proprietary technology and manufacturing platform, RNA Armory ®, is designed to enable precision control and optimization of engineered cells for diverse cell therapies …See details»

Cartesian Therapeutics Announces Presentation at the Upcoming …

Nov 5, 2024 The Company’s clinical-stage pipeline also includes Descartes-15, a next generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit …See details»

linkstock.net © 2022. All rights reserved